Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ferrocene. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101113138B details a safe cyanation method using ferrocene imine cyclopalladium complexes. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112824422B discloses a novel chiral ligand enabling high TON asymmetric hydrogenation for pharma intermediates with simplified synthesis.
Patent CN108929345A reveals stable ferrocene ligands for asymmetric hydrogenation. Enhances purity and reduces processing costs for pharmaceutical intermediate manufacturing supply chains.
Novel solvent-free method for acyl ferrocene hydrazinodithioformate Schiff base. High yield, green chemistry, cost-effective manufacturing for pharma intermediates.
Patent CN105859800B details a high-yield synthesis of chiral ferrocene P,P ligands. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel imidazolium-functionalized ferrocene ligands enable high-yield asymmetric allylic substitution with recyclable catalyst properties for pharmaceutical intermediates.
Patent CN109678911B details a high-efficiency Rh-catalyzed method for planar chiral ferrocene intermediates, offering superior enantioselectivity and supply chain reliability.
Patent CN114539328B reveals surfactant-promoted route enhancing yield and purity. Delivers supply chain stability and cost efficiency for global buyers.
Patent CN101486737A discloses a novel quaternary ammonium ferrocene ligand enabling high-yield asymmetric allylic substitution with simplified catalyst recovery for cost-effective manufacturing.
Patent CN103193830A reveals a flexible route for chiral ferrocene phosphine ligands, offering cost reduction in pharmaceutical intermediate manufacturing and reliable supply.
Patent CN114409714B reveals a palladium-catalyzed route for planar chiral ferrocenes. This method offers high enantioselectivity and scalable manufacturing for global supply chains.
Discover advanced ferrocene-based PNN ligands from patent CN114644663A for high-efficiency ketone hydrogenation, offering reliable supply and cost-effective pharma intermediate manufacturing.
Patent CN114409714B discloses a Pd-catalyzed method for 1 3-disubstituted planar chiral metallocenes offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN114409714A reveals a novel Pd-catalyzed method for synthesizing high-purity 1,3-disubstituted planar chiral metallocenes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel palladacycle catalyst enables high-yield aryl nitrile synthesis using safe potassium ferrocyanide, offering cost-effective pharma intermediate solutions.
Solve C-H activation challenges in pharmaceutical intermediates with green protonic acid catalysis. 91% yield, no precious metals, and industrial scalability for R&D and procurement teams.
Discover how novel oxygen-substituted ferrocene ligands enable 99% ee and 98% yield in asymmetric cycloaddition, reducing R&D costs and supply chain risks for API manufacturing.
Discover a novel palladium-catalyzed method for direct construction of two connected tertiary carbon bonds with high yield and optical purity. Ideal for pharmaceutical and fine chemical manufacturing.
Overcome low yields in ferrocene-Schiff base synthesis with solvent-free methods. Discover green, high-yield routes for advanced materials. Source reliable intermediates from NINGBO INNO PHARMCHEM.